Analysis of cellular immunofluorescent intensity of GFP+ tumor cells confirmed that the level of ASCL1 was elevated by about 2-fold compared to control or Olig2-CKO tumor cells (Fig. 3f). The gene discussed is ASCL1; the disease is neoplasm.